Attached files

file filename
8-K - FORM 8-K - CYBEX INTERNATIONAL INCd427457d8k.htm

Exhibit 99.1

 

LOGO

 

COMPANY    Arthur W. Hicks, Jr.
CONTACT:    President and COO
   (508) 533-4300

FOR IMMEDIATE RELEASE

CYBEX ANNOUNCES THIRD QUARTER RESULTS

MEDWAY, MA, October 23, 2012 — Cybex International, Inc. (NASDAQ: CYBI), a leading U.S. manufacturer of premium exercise equipment, today reported results for its third quarter ended September 29, 2012. Net sales for the third quarter of 2012 were $34.4 million, compared to $33.5 million for the corresponding 2011 period. The Company reported net income for the third quarter of 2012 of $1.1 million, or $0.06 per diluted share, compared to a net loss of $0.3 million, or $0.02 per diluted share, for the corresponding 2011 period.

For the nine months ended September 29, 2012, net sales were $102.4 million, compared to $97.1 million for 2011. Net income for the nine months ended September 29, 2012 was $0.3 million, or $0.02 per diluted share, compared to a net loss of $0.5 million, or $0.03 per diluted share, for 2011.

The above results include litigation charges of $1.4 million and $3.0 million for the quarter and nine months ended September 24, 2011, respectively, and litigation charges (reduction) of ($0.1 million) for the quarter ended September 29, 2012, related to the Barnhard product liability judgment. As previously reported, this litigation was settled during the first quarter of 2012.

Cybex Chairman and CEO John Aglialoro stated, “Q3 showed improvement compared to the previous quarter although the current economic environment continues to be challenging. While it is difficult to predict the short-term impact of economic conditions, we remain optimistic about sales prospects over the longer-term.”

Cybex President and COO Art Hicks stated, “We look forward to the Q4 introduction of our 525 cardio line which is targeted to better reach light commercial market segments. These products will feature lower price points, valuing ease of use and durability. Third quarter gross margins improved compared to Q2; and we expect this slow improvement trend to continue as we gain experience with our new 625 and 770 product lines. The Bravo strength series continues to be attractive to customers with functional training areas, which is a trend in the club market.”

- more -


As previously announced, the Company’s board of directors has approved an Agreement and Plan of Merger pursuant to which all of the Company’s outstanding common stock - other than shares owned by the Company’s largest shareholder, UM Holdings, Ltd. (“UM”), and UM’s subsidiaries and shareholders, which include John Aglialoro and Joan Carter - would be converted into $2.55 per share payable in cash, in a “going private” merger transaction. Mr. Aglialoro is Cybex’s chairman and CEO and Ms. Carter is a director.

Consummation of the merger is subject to various conditions, including approval of the Merger Agreement by the affirmative vote of two-thirds of all outstanding shares and a majority of the shares held by the public shareholders, and consummation of financing. While there can be no assurance that the merger will be approved by the shareholders or consummated, the Company anticipates that it will seek approval of the merger at a special Shareholders Meeting to be held during the first quarter of 2013 and that the transaction will close shortly thereafter.

If the merger is approved and consummated, shares of the Company’s common stock (other than shares held by UM, Mr. Aglialoro and Ms. Carter) will be deregistered under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), the Company will no longer be subject to the reporting requirements of the Exchange Act, and the shares will no longer trade on any market.

There is no investor conference call scheduled this quarter.

About Cybex

Cybex International, Inc. is a leading manufacturer of premium exercise equipment primarily for commercial use. The Cybex product line, including a full range of strength and cardio training machines, is designed using exercise science to reflect the natural movement of the human body. Led by the Cybex Research Institute, Cybex fitness equipment is engineered to produce optimal results for users from the first-time exerciser to the professional athlete. Cybex designs and builds its products in the USA for a wide range of facilities, from commercial health clubs to home gyms, in more than 85 countries worldwide. For more information on Cybex and its products, visit the Company’s website at www.cybexintl.com.

This news release may contain forward-looking statements. There are a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made above. These include, but are not limited to, the ability of the Company to comply with the terms of its credit facilities, competitive factors, technological and product developments, market demand, economic conditions, and the resolution of litigation involving the Company. Further information on these and other factors which could affect the Company’s financial results can be found in the Company’s previously filed Report on Form 10-K for the year ended December 31, 2011, its Reports on Form 10-Q, its Current Reports on Form 8-K, and its proxy statement dated April 12, 2012.

- Financial Tables to Follow -

 

- 2 -


CYBEX INTERNATIONAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(unaudited)

 

     Three Months Ended     Nine Months Ended  
     September 29,
2012
    September 24,
2011
    September 29,
2012
    September 24,
2011
 

Net sales

   $ 34,368     $ 33,478     $ 102,427     $ 97,054  

Cost of sales

     22,942       21,728       69,686       63,053  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     11,426       11,750       32,741       34,001  

As a percentage of sales

     33.3 %     35.1 %     32.0 %     35.0 %

Selling, general and administrative expenses

     10,154       10,404       31,498       30,818  

Litigation charge (reduction)

     (68 )     1,362       —          3,005  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (loss)

     1,340       (16 )     1,243       178  

Interest expense, net

     331       240       946       781  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

     1,009       (256 )     297       (603 )

Income tax expense (benefit)

     (74 )     22       (49 )     (149 )
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ 1,083     $ (278 )   $ 346     $ (454 )
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic and diluted net income (loss) per share

   $ 0.06     $ (0.02 )   $ 0.02     $ (0.03 )
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computing basic net income (loss) per share

     17,141       17,120       17,130       17,120  
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computing diluted net income (loss) per share

     17,236       17,120       17,249       17,120  
  

 

 

   

 

 

   

 

 

   

 

 

 

- more -

 

- 3 -


CYBEX INTERNATIONAL, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(unaudited)

 

     September 29,
2012
     December 31,
2011
 

ASSETS

     

Current assets:

     

Cash and cash equivalents

   $ 2,181      $ 11,958  

Accounts receivable, net

     18,620        20,251  

Inventories

     14,258        13,584  

Prepaid expenses and other

     1,596        2,070  

Barnhard litigation related receivable

     —           7,561  
  

 

 

    

 

 

 

Total current assets

     36,655        55,424  

Property and equipment, net

     27,131        28,194  

Other assets

     827        1,025  
  

 

 

    

 

 

 
   $ 64,613      $ 84,643  
  

 

 

    

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

     

Current liabilities:

     

Current maturities of long-term debt

   $ 2,061      $ 1,520  

Accounts payable

     5,302        5,364  

Accrued expenses

     12,295        13,674  

Barnhard litigation reserve

     —           27,004  
  

 

 

    

 

 

 

Total current liabilities

     19,658        47,562  

Long-term debt

     18,939        12,769  

Other liabilities

     5,579        4,674  
  

 

 

    

 

 

 

Total liabilities

     44,176        65,005  

Stockholders’ equity

     20,437        19,638  
  

 

 

    

 

 

 
   $ 64,613      $ 84,643  
  

 

 

    

 

 

 

#####

 

- 4 -